Cefoperazone/Sulbactam in the treatment of healthcare-associated pneumonia
PP-MGX-IND-0373
Effective and well-tolerated antibiotic
PP-MGX-IND-0375
PP-MGX-IND-0376
PP-MGX-IND-0374
Reference:
1. Magnex. Local product document. Pfizer; 2020. Version LPDMGX042020.
Please click the Prescribing Information link to view the safety and adverse events information of MAGNEX®.
For the use only of registered medical practitioner, or a hospital or a laboratory.
These pages are not intended for patients or for members of the general public. The web pages contain promotional content.
If you select 'No', you will be redirected to Pfizer.co.in
For more details on, Who is a Registered medical practitioner*, please visit "https://cdsco.gov.in/opencms/export/sites/CDSCO_WEB/Pdf-documents/acts_rules/2016DrugsandCosmeticsAct1940Rules1945.pdf", Page No. 39, Rule 2 part (ee), last accessed on 26th April 2021.
Address: The Capital, A Wing, 1802, 18th Floor, Plot No. C-70, 'G' Block, Bandra Kurla Complex, Bandra East, Mumbai - 400051.